Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXTBiotechnology
+$0.46 today
- Market cap
- $89.11M
- Beta
- 1.05
- P/E (TTM)
- -11.1
- EPS (TTM)
- -$0.67
Volume 0.61M
Average 0.12M
LIXT Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Lixte Biotechnology Holdings, Inc.NASDAQ: LIXT
Accounts Payables · Q1 FY2026 · quarter ended Mar 2026
Accounts payables turns negative
Q1 FY2026 accounts payables was -$45.4K, compared with $56.77K a year earlier. Trailing-twelve-month accounts payables was -$6.51K.
Context
- Accounts payables increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly accounts payables holds near -$45.4K or moves back toward the trailing-twelve-month quarterly average of -$1.63K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- +100.0%
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | +100.0% |
| FY2024 | 2024-12-31 | (73.55K) | +0.6% |
| FY2023 | 2023-12-31 | (73.98K) | -3291.4% |
| FY2022 | 2022-12-31 | 2.32K | -93.5% |
| FY2021 | 2021-12-31 | 35.67K | — |
Accounts Payables vs competitors
How LIXT compares with its peers on the latest reported figures
- LIXT's LTM Mar 2026 accounts payables of $6.51K is the largest of the 2 companies compared; the peer median is $0.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $6.51K | -93.9% | — | — | |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding LIXT) | $0 | — | — | — | |
Competitors are the stored peer set for LIXT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Lixte Biotechnology Holdings, Inc.
NASDAQ:LIXT
Intrinsic Alpha fair value
Locked
Current Price
$7.21
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.